ACTIVE

SYNABS

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
83,2 k €
-81.9% YoY
Gross margin
742,6 k €
-48.4% YoY
Equity
747 k €
+12.4% YoY
Workforce
5,1 ETP
-16.4% YoY

What does SYNABS do?

SYNABS is a Public limited company incorporated in 2015. Its main activity is: Manufacture of other chemical products n.e.c.. Its registered office is in Charleroi. It employs on average 5,1 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0637.716.206
Incorporation
14/09/2015
Legal form
Public limited company
Registered office
Rue Auguste Piccard 48
6041 Charleroi · WallonieSee on map
Contributed capital
360 000,00 €
Latest accounts
31/12/2025
Average workforce
5,1 ETP
Activities (NACE)
20590Manufacture of other chemical products n.e.c.· main20590Manufacture of other chemical products n.e.c.72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology
Joint committees (1)
  • 207
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 10 financial years

2025202420232022202120202019201820172016
Income statement
Gross margin742,6 k €1,4 M €1,2 M €840,8 k €784,1 k €482,9 k €852,9 k €512,4 k €432,8 k €298,6 k €
EBITDA356,9 k €1 M €752,7 k €332,4 k €406,6 k €125,9 k €444,6 k €181,4 k €107,4 k €-49,5 k €
Operating result-119,7 k €216,2 k €63 k €-313,6 k €-57 k €-261,5 k €-100,9 k €-113,9 k €-51,4 k €-120,3 k €
Net result83,2 k €458,8 k €508,4 k €55,6 k €182,6 k €-65,4 k €109,3 k €31,3 k €2,1 k €-120,8 k €
Balance sheet
Equity747 k €664,5 k €509 k €501,2 k €508,9 k €331,8 k €387,6 k €281,2 k €225 k €215,7 k €
Total assets1,1 M €1,7 M €1,5 M €1,2 M €886,1 k €860,1 k €835,3 k €919 k €767,3 k €501,7 k €
Cash72,4 k €700 k €395 k €374,7 k €115,8 k €356 k €183,8 k €259,6 k €108,6 k €114,8 k €
Debts359,5 k €1 M €957,4 k €613,8 k €377,1 k €524,9 k €444,8 k €606,7 k €500,3 k €241,1 k €
Other
Workforce5,1 ETP6,1 ETP6,6 ETP7,4 ETP6,3 ETP7,8 ETP8,9 ETP5,9 ETP–3,6 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 18 ended

Active mandates

ISY INVEST

Director · since 22 juin 2022 · until 21 juin 2028 · 0773.549.264

Represented by ISOARD JULIEN

Active

Ended mandates

CHRISTOPHE MATHIEU

Director · since 22 juin 2022 · until 21 juin 2028

Ended
Philippe DULIEU

Director · since 22 juin 2022 · until 15 juin 2023

Ended
ISY BIO

Director · since 03 décembre 2020 · until 02 décembre 2026 · 0597.965.309

Represented by ISOARD JULIEN

Ended
ISY BIO

Managing director · since 03 décembre 2020 · until 02 décembre 2026 · 0597.965.309

Represented by Julien ISOARD

Ended
At this address

Other companies at this address

CompanyCBE no.
CANCER STATE THERAPEUTICS● Active
0793.113.273
European Infrared Technologies● Active
0643.646.468
Genflow Biosciences● Active
0753.904.685
HEARTKINETICS● Bankrupt
0728.461.387
NEUVASQ BIOTECHNOLOGIES● Active
0762.966.663
T-knife Therapeutics● Active
1037.005.620
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/06/202604/04/202517/05/202405/07/202318/07/202215/07/2021
General meeting18/06/202626/03/202502/05/202415/06/202322/06/202206/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

11 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202518/06/202622/06/2026FrenchPDF
Abridged model31/12/202426/03/202504/04/2025FrenchPDF
Abridged model31/12/202302/05/202417/05/2024FrenchPDF
Abridged model31/12/202215/06/202305/07/2023FrenchPDF
Abridged model31/12/202122/06/202218/07/2022FrenchPDF
Abridged model31/12/202006/07/202115/07/2021FrenchPDF
Abridged model31/12/201918/06/202001/07/2020FrenchPDF
Abridged model31/12/201816/05/201921/05/2019FrenchPDF
Micro modelCorrection31/12/201724/05/201811/09/2018FrenchPDF
Micro model31/12/201724/05/201808/06/2018FrenchPDF
Abridged model31/12/201628/04/201729/05/2017FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 18 ended

Active mandates

ISY INVEST

Director · since 22 juin 2022 · until 21 juin 2028 · 0773.549.264

Represented by ISOARD JULIEN

Active

Ended mandates

CHRISTOPHE MATHIEU

Director · since 22 juin 2022 · until 21 juin 2028

Ended
Philippe DULIEU

Director · since 22 juin 2022 · until 15 juin 2023

Ended
ISY BIO

Director · since 03 décembre 2020 · until 02 décembre 2026 · 0597.965.309

Represented by ISOARD JULIEN

Ended
ISY BIO

Managing director · since 03 décembre 2020 · until 02 décembre 2026 · 0597.965.309

Represented by Julien ISOARD

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates30/11/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates02/08/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates13/08/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates04/07/2018
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DIVERS - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office16/06/2017
    SIEGE SOCIAL
    PDF
  • Capital / shares07/10/2015
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Other16/09/2015
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202583,2 k €↓
  2. 2024
    Annual accounts 2024458,8 k €↓
  3. 2023
    Annual accounts 2023508,4 k €↑
  4. 2022
    Annual accounts 202255,6 k €↓
  5. 2021
    Annual accounts 2021182,6 k €↑
  6. 2020
    Annual accounts 2020-65,4 k €↓
  7. 2019
    Annual accounts 2019109,3 k €↑
  8. 2018
    Annual accounts 201831,3 k €↑
  9. 2017
    Annual accounts 20172,1 k €↑
  10. 2016
    Annual accounts 2016-120,8 k €
  11. 14/09/2015
    IncorporationPublic limited company